New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
18:07 EDTAMGN, CVS, VZSEC probes Ernst & Young on lobbying issue, Reuters says
The SEC's enforcement division and its Office of the Chief Accountant are looking in to a report that Washington Council Ernst & Young was registered as a lobbyist for several corporate audit clients including Amgen (AMGN), CVS Caremark (CVS) and Verizon Communications (VZ), says Reuters, citing people familiar with the matter. Reference Link
News For AMGN;CVS;VZ From The Last 14 Days
Check below for free stories on AMGN;CVS;VZ the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
07:54 EDTVZVerizon 2014 consensus estimates have upside, says Jefferies
Jefferies sees upside to the 2014 consensus estimates for Verizon given the better than expected equipment installment plans market. The firm sees 17% upside to its year-end price target of $55 and it keeps a Buy rating on Verizon.
April 15, 2014
13:49 EDTVZEarnings Preview: Analysts optimistic on Intel ahead of Q1 report
Subscribe for More Information
April 14, 2014
09:10 EDTVZT-Mobile CEO starts petition for consumers to call on peers to end overages
Subscribe for More Information
09:05 EDTVZT-Mobile abolishes consumer overages, challenges other providers to follow suit
T-Mobile (TMUS) announced a campaign to eliminate overage penalties, one of the most reviled wireless industry practices. While abolishing overages for all customers on T-Mobile consumer plans, its CEO has also laid down a challenge to the nation's largest carriers, AT&T (T), Verizon (VZ) and Sprint (S), to do the same.
07:06 EDTVZU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
April 11, 2014
09:19 EDTVZANADIGICS ships AWC6383 dual-band ProVantage PA to Samsung
Subscribe for More Information
07:26 EDTVZTime Warner struggling to force Dodgers network on pay-TV players, LAT say
Subscribe for More Information
April 10, 2014
11:23 EDTCVSRite Aid hits 52-week high after results, sales view top estimates
Shares of retail drugstore Rite Aid (RAD) are rallying after the company's fourth quarter results and fiscal 2015 revenue outlook topped analysts' consensus estimates. WHAT'S NEW: This morning, Rite Aid reported fourth quarter adjusted earnings per share of 10c and revenue of $6.6B, compared to expectations of 4c and $6.54B, respectively. Q4 same store sales increased 2.1%. Rite Aid forecast FY15 EPS of 31c-42c, compared to the consensus of 35c. FY15 revenue was seen at $26B-$26.5B, ahead of the consensus $25.75B. FY15 same-store sales are expected by the company to be up 2.5%-4.5%. WHAT'S NOTABLE: Rite Aid also announced it has acquired RediClinic, which currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Rite Aid CEO John Standley said, “Our recent acquisitions of Health Dialog and RediClinic, our expanded partnership with McKesson and our continued commitment to investing in our store base have positioned us to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail healthcare company.” PRICE ACTION: In late morning trading, Rite Aid rose 71c, or about 11%, to $7.11 on more than twice its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week high of $7.39. Including today's advance, the stock is up approximately 300% over the past twelve months. OTHERS TO WATCH: Other retail drugstore operators include Walgreen Company (WAG) and CVS Caremark (CVS).
April 9, 2014
11:15 EDTVZT-Mobile unveils $40 monthly price plan called 'Simple Starter'
Subscribe for More Information
April 8, 2014
13:24 EDTCVSCVS confirms final SEC settlement, says will not be required to restate earnings
Subscribe for More Information
13:08 EDTCVSCVS Caremark pays $20M to settle SEC accounting charges
The SEC announced that it charged CVS Caremark "with misleading investors about significant financial setbacks and using improper accounting that artificially boosted its financial performance." CVS has agreed to pay $20M to settle the charges, the agency said. Reference Link
11:03 EDTAMGNPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
07:14 EDTVZAT&T wants to force customers in Alabama town to switch to wireless, WSJ reports
Subscribe for More Information
April 7, 2014
16:01 EDTVZOptions Update; April 7, 2014
Subscribe for More Information
09:34 EDTVZActive equity options trading on open
Subscribe for More Information
07:24 EDTCVSCVS Caremark price target raised to $84-$89 from $75-$80 at Wells Fargo
Subscribe for More Information
07:04 EDTVZCincinnati Bell to sell wireless spectrum licenses to Verizon Wireless
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use